LONA
$9.92-0.01 (-0.10%)
Market ClosedAs of Mar 20, 8:00 PM UTC
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$9.92
Potential Upside
5%
Whystock Fair Value$10.42
Price
UndervaluedFair ValueOvervalued
Fundamentals
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$92.61M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.76
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-140.83%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
9.70
Recent News
No recent news found.